VENKATA DEVABHAKTUNI: Open Payments
NPI 1891734752 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 35 payments from 9 companies in 2025. Trend: 2023 $243 · 2024 $239 · 2025 $785
Food & beverage: $785
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $190 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $151 |
| Axsome Therapeutics, Inc. | 4 | $151 |
| Teva Pharmaceuticals USA, Inc. | 2 | $126 |
| Vanda Pharmaceuticals Inc. | 3 | $57 |
| Corium, LLC | 3 | $41 |
| ABBVIE INC. | 2 | $36 |
| Alkermes, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: CAPLYTA, Auvelity, SPRAVATO, UZEDY, FANAPT, INVEGA SUSTENNA, Azstarys, VRAYLAR.
Industry payments across AL — which companies pay providers there.
